Portfolio Careers

General Interest - UK-based positions

Portal Biotech

Portal Biotech

Remote
Posted on Sep 22, 2025
London · Hybrid

General Interest - UK-based positions

Portal Biotech is continuously looking for new talent to join our teams and take ownership of exciting new challenges in our mission to develop the first benchtop single-molecule protein sequencer.

We usually respond within a month

Could not find the opportunity you are looking for?

You can connect with us to stay in touch with Portal Biotech or submit a general application over here for our team to review. As we grow, new opportunities will be opened and we will be looking for sharp and motivated talent to tackle exciting challenges!

If you submit your application over here, make sure to highlight to us the kind of opportunity you are looking for and where you see your value proposition to the company (i.e., where you would best fit our team).

Note: if you are applying to other jobs suitable to your experience and skills, please do not apply again using this link.

Locations
London
Remote status
Hybrid

About Portal Biotech

Founded by DNA-sequencing veterans, Portal Biotech is developing the first bench-top single-molecule protein sequencer, leveraging machine-learning algorithms and building on decades of in-house expertise in nanopore technology. By analysing full-length protein molecules at the single-molecule level, our platform delivers rapid, real-time information on protein identity, abundance, and structure. Those insights open frontiers in drug discovery, diagnostics, and fundamental research, helping scientists and clinicians to better understand human health and disease.

Founded in 2021
London · Hybrid

General Interest - UK-based positions

Portal Biotech is continuously looking for new talent to join our teams and take ownership of exciting new challenges in our mission to develop the first benchtop single-molecule protein sequencer.

Already working at Portal Biotech?

Let’s recruit together and find your next colleague.